Laura Meléndez‐Alafort

Author

Also Known As

L Melendez-Alafort, L Meléndez-Alafort, L. MELENDEZ-ALAFORT, L. Melendez Alafort, L. Melendez-Alafort, L. Melendez‐Alafort, L. Meléndez-Alafort, L.M. Alafort, Laura Melendez Alafort, Laura Melendez-Alafort

113

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Istituto Oncologico Veneto Instituto Nacional de Investigaciones Nucleares University of Padua Istituti di Ricovero e Cura a Carattere Scientifico Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

About

Laura Meléndez‐Alafort is an author at Istituto Oncologico Veneto specializing in medicine, radiation oncology, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	465
2	Engineering	11	11	268
3	Biochemistry	5	5	103
4	Health Sciences	4	4	75
5	Natural Sciences	4	4	87

Laura Meléndez‐Alafort

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
99mTc-HYNIC-[Tyr3]-octreotide for imaging somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide. Clemens Decristoforo, Laura Meléndez‐Alafort, Jane Sosabowski, PubMed	2000	162
A Paclitaxel-Hyaluronan Bioconjugate Targeting Ovarian Cancer Affords a Potent <i>In vivo</i> Therapeutic Activity Alessandra Banzato, Sara Bobisse, Maria Rondina, Clinical Cancer Research	2008	89
Biokinetics of 99mTc-UBI 29-41 in humans Laura Meléndez‐Alafort, J. Rodríguez-Cortés, Guillermina Ferro‐Flores, Nuclear Medicine and Biology Radiation OncologyHuman CellNuclear MedicineClinical Chemistry	2004	83
In vitro and in vivo assessment of 99mTc-UBI specificity for bacteria Guillermina Ferro‐Flores, Consuelo Arteaga de Murphy, Martha Pedraza-López, Nuclear Medicine and Biology 99Mtc-ubi SpecificityMedical MicrobiologyBacteriologyVivo AssessmentMicrobiology	2003	81
177Lu-Bombesin-PLGA (paclitaxel): A targeted controlled-release nanomedicine for bimodal therapy of breast cancer Brenda Gibbens-Bandala, Enrique Morales-Ávila, Guillermina Ferro‐Flores, Materials Science and Engineering C NanomedicineBimodal TherapyDrug TargetingNanotherapeuticsEngineering	2019	61
Detection of sites of infection in mice using 99mTc-labeled PN2S-PEG conjugated to UBI and 99mTc-UBI: a comparative biodistribution study Laura Meléndez‐Alafort, Anna Nadali, Gianfranco Pasut, Nuclear Medicine and Biology Laboratory ImmunologyImmunology99Mtc-labeled Pn2s-pegMedicineCell Biology	2009	43
In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals Petra Martini, Alessandra Boschi, Gianfranco Cicoria, Applied Radiation and Isotopes In-house Cyclotron ProductionRadiopharmaceuticalsRadioanalytical ChemistrySynthetic ElementRadiopharmaceutical Therapy	2018	42
Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines Anna Dalla Pietà, Debora Carpanese, Antonella Grigoletto, Cellular and Molecular Immunology	2021	39
Design, Synthesis and Preclinical Assessment of 99mTc-iFAP for In Vivo Fibroblast Activation Protein (FAP) Imaging Diana Trujillo-Benítez, Myrna Luna‐Gutiérrez, Guillermina Ferro‐Flores, Molecules	2022	39
Lys and Arg in UBI: A specific site for a stable Tc-99m complex? Laura Meléndez‐Alafort, Flor de Marı́a Ramı́rez, Guillermina Ferro‐Flores, Nuclear Medicine and Biology EngineeringParticle PhysicsSpecific SiteComputer EngineeringSystems Engineering	2003	38

Page 1